Advertisement
Loading...

Royalty Pharma plc

RPRX•NASDAQ
Healthcare
Biotechnology
$52.14
$-1.11(-2.08%)
U.S. Market is Open • 10:40

Royalty Pharma plc (RPRX) Stock Overview

Explore Royalty Pharma plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap23B
P/E Ratio27.81
EPS (TTM)$1.90
ROE0.13%
Fundamental Analysis

AI Price Forecasts

1 Month$47.41
3 Months$47.21
1 Year Target$50.45

RPRX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Royalty Pharma plc (RPRX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 76.39, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $50.45.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 27.81 and a market capitalization of 23B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.28%
5-Day Change
5.16%
1-Month Change
9.38%
3-Month Change
18.17%
6-Month Change
36.36%
Year-to-Date (YTD) Change
38.20%
1-Year Change
65.38%
3-Year Change
55.55%
5-Year Change
31.11%
All-Time (Max) Change
20.00%

Contact Information

https://www.royaltypharma.com
212 883 0200
110 East 59th Street, New York City, NY, 10022

Company Facts

75 Employees
IPO DateJun 16, 2020
CountryUS
Actively Trading

Frequently Asked Questions